CONTRATOS DE INVESTIGACIÓN
Contract 2023/076
Análisis de datos clínicos y farmacológicos de los medicamentos biosimilares de eculizumab.
Funder:
ALEXION PHARMA SPAIN, SL
date_range
Duration: from 19 May 2023 to 30 November 2023
(6 months)
Finished
Of National scope. It has been granted under a regime of Direct grant.
Call:
(ALEXION PHARMA SPAIN, SL)
Researchers
Lucinda
Villaescusa Castillo
Leader
Cristina
Zaragozá Arnáez
Leader